Liquid Wart Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily as necessary. Treatment can continue for a duration of up to 12 weeks, or until the wart is removed.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product except under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. Application is also contraindicated on genital warts and warts located on the face. The product should not be applied to moles, birthmarks, or warts with hair growing from them. Additionally, it is contraindicated for use on mucous membranes and on skin that is irritated, infected, or reddened.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product should not be used by individuals who are diabetic or have poor blood circulation unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist. Additionally, it is contraindicated for use on genital warts, warts located on the face, moles, birthmarks, and warts with hair growing from them. The product must not be applied to mucous membranes or on skin that is irritated, infected, or reddened.

When using this product, it is crucial to avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for at least 15 minutes. Users should also take care to avoid inhaling vapors associated with the product.

If discomfort persists, it is advised to discontinue use and consult a healthcare professional for further evaluation.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. The product should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be used on mucous membranes or on skin that is irritated, infected, or reddened.

During use, patients should take care to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors from the product.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. It is important to keep this product out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Liquid Wart Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Liquid Wart Remover (salicylic acid liquid) during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the potential risks when prescribing this product to women of childbearing potential. It is advisable to weigh the benefits against any unknown risks to fetal outcomes.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. The potential risks and benefits should be carefully weighed in the context of the individual patient's situation.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, patients should be cautioned against using the product on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also important to instruct patients not to apply the product on mucous membranes or on skin that is irritated, infected, or reddened.

Patients should be advised to discontinue use and consult a doctor if discomfort persists. Furthermore, when using this product, patients should be reminded to avoid contact with their eyes. In case of contact, they should flush the eyes with water for 15 minutes. Lastly, patients should be cautioned to avoid inhaling vapors while using the product.

Storage and Handling

The product is supplied in a tightly capped bottle, which must be stored at room temperature, specifically between 20° - 25°C (68° - 77°F). It is essential to keep the container away from heat sources and to ensure that it is closed tightly to prevent solidification. Additionally, the product should be kept away from fire or flame and stored in a cool place to maintain its integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Liquid Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)